GERMAN chemicals giant Bayer reported Thursday a heavy fall in first-quarter profits, pulled down by falling sales of crucial weedkillers and drugs.
The poor results come as the maker of Aspirin faces a delicate transition to a new CEO, and as it contends with calls for a break-up from activist investors.